Giving new life to old lungs: methods to produce and assess whole human paediatric bioengineered lungs

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 7, 2017, Pages 2136-2152

  Nichols, Joan E ^a   La Francesca, Saverio ^b   Vega, Stephanie P ^a   Niles, Jean A ^a   Argueta, Lissenya B ^c   Riddle, Michael ^a   Sakamoto, Jason ^d   Vargas, Grace ^e   Pal, Rahul ^e   Woodson, Lee ^f   Rhudy, Jessica ^d   Lee, Dan ^d   Seanor, David ^e   Campbell, Gerald ^a   Schnadig, Vicki ^a   Cortiella, Joaquin ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Harvard Apparatus   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^f Shiners Hospital for Children   (United States)

Author keywords

bioengineered organs; bioengineered paediatric lungs; decellularized lung scaffold; human bioengineered lungs; laboratory grown lungs; laboratory grown paediatric lungs; platelet rich plasma; tissue engineered lungs

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; COPYRIGHTS; PEDIATRICS; SCAFFOLDS (BIOLOGY); TISSUE;

BIOENGINEERED ORGAN; BIOENGINEERED PEDIATRIC LUNG; DECELLULARIZED; DECELLULARIZED LUNG SCAFFOLD; HUMAN BIOENGINEERED LUNG; LABORATORY-GROWN LUNG; LABORATORY-GROWN PEDIATRIC LUNG; PLATELET RICH PLASMA; RECELLULARIZATION; TISSUE-ENGINEERED LUNG;

BIOLOGICAL ORGANS;

COLLAGEN TYPE 1; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

ADULT; ARTICLE; BIOENGINEERING; CELL COUNT; CELL ENGINEERING; CELL ISOLATION; CELL POPULATION; CELL VIABILITY; CHILD; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM CELL; LUNG COMPLIANCE; LUNG FUNCTION TEST; LUNG PARENCHYMA; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA; THROMBOCYTOPOIESIS; ANIMAL; BIOPROSTHESIS; BIOREACTOR; CHEMISTRY; CYTOLOGY; FEMALE; INFANT; LUNG; MALE; METABOLISM; NEWBORN; PRESCHOOL CHILD; PROCEDURES; TISSUE ENGINEERING; TISSUE SCAFFOLD;

ALVEOLAR EPITHELIAL CELLS; ANIMALS; BIOPROSTHESIS; BIOREACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LUNG; MALE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84954285814     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.2113     Document Type: Article

References (39)

1. ABCAM. http://www.abcam.com/ps/pdf/protocols/Immunoprecipitation%20protocol%20(IP).pdf [accessed 3 February 2014].
2. Alsousou J, Ali A, Willett K, et al. 2013; The role of platelet-rich plasma in tissue regeneration. Platelets 24: 173–182.
3. Araki J, Jona M, Eto H, et al. 2012; Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng C Methods 18: 176–185.
4. Arichi N, Mitsui Y, Ogawa K, et al. 2014; Intraoperative fluorescence vascular imaging using indocyanine green for assessment of transplanted kidney perfusion. Transpl Proc 46: 342–345.
5. Bonenfant NR, Sokocevic D, Wagner DE, et al. 2013; The effects of storage and sterilization on decellularized and recellularized whole lung. Biomaterials 34: 3231–3245.
6. Botha P, Clark SC, Dark JH 2010; Standardization of transplant procurement procedures. J Thorac Cardiovasc Surg 140: 250–251.
7. Campagnola PJ, Loew LM 2003; Second-harmonic imaging microscopy for visualizing biomolecular arrays in cells, tissues and organisms. Nat Biotechnol 21: 1356–1360.
8. Chen L, Acciani T, Le Cras T, et al. 2012a; Dynamic regulation of platelet-derived growth factor receptor-α expression in alveolar fibroblasts during realveolarization. Am J Respir Cell Mol Biol 47: 517–527.
9. Chen X, Nadiarynkh O, Plotnikov S, et al. 2012b; Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure. Nat Protoc 7: 654–669.
10. Cook GJ, Fogelman I, Maisey MN 1996; Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 26: 308–314.
11. Cortiella J, Nichols JE, Kojima K, et al. 2006; Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng 12: 1213–1225.
12. Cortiella J, Niles J, Cantu A, et al. 2010; Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng A 16: 2565–2580.
13. El-Daher N, Nichols JE, Roberts NJ Jr 1994; Analysis of human antiviral cytotoxic T-lymphocyte responses for vaccine trials using cryopreserved mononuclear leukocytes: demonstration of feasibility with influenza virus-specific responses. Clin Diagn Lab Immunol 1: 487–492.
14. Halbert CL, Demers GW, Galloway DA 1991; The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 65: 473–478.
15. Huang YQ, Sauthoff H, Herscovici P, et al. 2008; Angiopoietin-1 increases survival and reduces the development of lung edema induced by endotoxin administration in a murine model of acute lung injury. Crit Care Med 36: 262–267.
16. Khan MS, Heinle JS, Samayoa AX, et al. 2013; Is lung transplantation survival better in infants? Analysis of over 80 infants. J Heart Lung Transpl 32: 44–49.
17. Kostakoglu L, Hardoff R, Mirtcheva R, et al. 2004; PET–CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics 24: 1411–1431.
18. Lillehei CW, Shamberger RC, Mayer JE Jr, et al. 1994; Size disparity in pediatric lung transplantation. J Pediatr Surg 29: 1152–1155; discussion, 1155–1156.
19. Mallory GB, Spray TL 2004; Pediatric lung transplantation. Eur Respir J 24: 839–845.
20. Mondrinos MJ, Koutzaki S, Jiwanmall E, et al. 2006; Engineering three-dimensional pulmonary tissue constructs. Tissue Eng 12: 717–728.
21. Naumova AV, Modo M, Moore A, et al. 2014; Clinical imaging in regenerative medicine. Nat Biotechnol 32: 804–818.
22. Nichols JE, Niles J, Riddle M, et al. 2013; Production and assessment of decellularized pig and human lung scaffolds. Tissue Eng A 19: 2045–2062.
23. Nonaka PN, Campillo N, Uriarte JJ, et al. 2014; Effects of freezing/thawing on the mechanical properties of decellularized lungs. J Biomed Mater Res A 102: 413–419.
24. Opelz G, Susal C, Ruhenstroth A, et al. 2010; Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report. Transplantation 90: 912–917.
25. Quantz MA, Bennett LE, Meyer DM, et al. 2000; Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3549 lung transplantations. J Heart Lung Transpl 19: 473–479.
26. Sabashnikov A, Patil NP, Mohite PN, et al. 2014; Influence of donor smoking on midterm outcomes after lung transplantation. Ann Thorac Surg 97: 1015–1021.
27. Sanchez-Gonzalez DJ, Mendez-Bolaina E, Trejo-Bahena NI 2012; Platelet-rich plasma peptides: key for regeneration. Int J Pept 2012: 1–10.
28. Shigemura N, Bermudez C, Hattler BG, et al. 2009; Impact of graft volume reduction for oversized grafts after lung transplantation on outcome in recipients with end-stage restrictive pulmonary diseases. J Heart Lung Transpl 28: 130–134.
29. Shigemura N, D'Cunha J, Bhama JK, et al. 2013; Lobar lung transplantation: a relevant surgical option in the current era of lung allocation score. Ann Thorac Surg 96: 451–456.
30. Sun J, Shilagard T, Bell B, et al. 2004; In vivo multimodal nonlinear optical imaging of mucosal tissue. Opt Express 12: 2478–2486.
31. Sweet SC 2009; Pediatric lung transplantation. Proc Am Thorac Soc 6: 122–127.
32. Taggart DP, Choudhary B, Anastasiadis K, et al. 2003; Preliminary experience with a novel intraoperative fluorescence imaging technique to evaluate the patency of bypass grafts in total arterial revascularization. Ann Thorac Surg 75: 870–873.
33. Taghavi S, Jayarajan S, Komaroff E, et al. 2013; Double-lung transplantation can be safely performed using donors with heavy smoking history. Ann Thorac Surg 95: 1912–1917 discussion, 1917–1918.
34. Thurston G, Rudge JS, Ioffe E, et al. 2000; Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460–463.
35. Van Raemdonck DI 2009; Lung donor selection and management. Proc Am Thorac Soc 6: 28–38.
36. Wilkes DS, Egan TM, Reynolds HY 2005; Lung transplantation: opportunities for research and clinical advancement. Am J Respir Crit Care Med 172: 944–955.
37. Wirz S, Dietrich M, Flanagan TC, et al. 2011; Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels. Tissue Eng A 17: 1891–1899.
38. Zipfel WR, Williams RM, Christie R, et al. 2003; Live tissue intrinsic emission microscopy using multiphoton-excited native fluorescence and second harmonic generation. Proc Natl Acad Sci U S A 10: 7075–7080.
39. Zych B, García Sáez D, Sabashnikov A, et al. 2014; Lung transplantation from donors outside standard acceptability criteria are they really marginal? Transpl Int 27: 1183–1191.